eHealth, Inc. (EHTH) 股票分析

公司概述

eHealth, Inc. operates as a health insurance marketplace in the United States, providing consumer engagement, education, and enrollment solutions specifically within the Medicare, Employer, and Individual segments. This entity functions within the Financial Services sector, specifically under the Insurance Brokers industry, positioning it as a key intermediary connecting consumers with health coverage options. The company's current market capitalization stands at $41.02M, supported by a trailing twelve-month revenue of $554.01M and an employee base of 1,665. These valuation and revenue figures indicate that eHealth, Inc. maintains a significant operational scale despite a relatively modest market cap, suggesting a business model where revenue generation is decoupled from immediate equity valuation, potentially reflecting market skepticism regarding future profitability or a specific valuation structure common in the brokerage sector.

财务健康

eHealth, Inc. reported a trailing twelve-month revenue of $554.01M, while recording a net income of -$10,404,000 and an EBITDA of $70.38M. The substantial gap between the positive EBITDA of $70.38M and the negative net income of -$10.404M reveals a significant cost structure driven by non-operating expenses or interest costs that erode operating earnings before reaching the bottom line. The company generated free cash flow of $68.12M, which provides a robust measure of financial flexibility by highlighting the ability to generate cash from operations even while reporting accounting losses. Regarding profitability margins, the gross margin is listed at 100.0%, indicating that the cost of goods sold is negligible or non-existent for this brokerage model; however, the operating margin of 38.7% and profit margin of 7.2% demonstrate that while operational efficiency is high, the bottom line is heavily impacted by other factors. On the balance sheet, cash holdings of $77.22M are compared against total debt of $134.35M, resulting in a debt-to-equity ratio of 13.80, which characterizes the balance sheet as highly leveraged rather than conservative. Despite the high leverage, the current ratio of 3.38 indicates strong short-term liquidity, suggesting the company can easily meet its immediate financial obligations. Return on equity stands at 4.2% and return on assets is 3.5%, metrics that, in the context of negative net income, reveal that management effectiveness in generating shareholder value is currently challenged by the reported losses.

估值评估

The valuation metrics present a complex picture with a P/E Ratio (TTM) listed as N/A due to negative earnings, while the forward P/E is 1.28. The absence of a trailing P/E combined with a low forward P/E of 1.28 implies that the market is pricing in an expectation of significant earnings recovery or a restructuring of the company's income statement in the near term. The price-to-book ratio is 0.07, indicating that the market values the company at a fraction of its book value, suggesting a deep discount relative to the net asset value recorded on the balance sheet. Alternative valuation metrics further support this discount, with a price-to-sales ratio of 0.07 and an EV/EBITDA of 6.82, suggesting the market assigns a low multiple to its sales and strong cash generation capabilities. In terms of trading range, the stock has a 52-week high of $7.09 and a 52-week low of $1.20, meaning the current price sits at the lower end of this historical range, reflecting recent market weakness. The beta value of 1.15 indicates that the stock's price volatility is higher than the broader market, meaning it tends to move with greater intensity than the overall market index during periods of volatility.

Growth & Income

The company's growth profile shows a revenue growth year-over-year of 3.5%, while earnings growth year-over-year is -17.6%. This divergence implies that earnings are growing slower than revenue, specifically contracting while sales expand, which highlights the difficulty in translating top-line growth into bottom-line profitability for eHealth, Inc. regarding income, the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the company reinvests all available earnings or retains capital to fund operations and growth initiatives rather than distributing cash to shareholders. The overall growth and income profile suggests a business focused on capital preservation and operational scaling rather than current income generation or dividend yields.